Resveratrol Inhibits Hepatocellular Carcinoma Progression through Regulating Exosome Secretion


Цитировать

Полный текст

Аннотация

Background and Objectives:Resveratrol is a promising drug for tumor therapy, but its anti-tumor mechanism remains unclarified. The present study aimed to explore the effect of resveratrol on the secretion of exosomes and the role of resveratrol-induced exosomes in the progression of hepatocellular carcinoma.

Methods:The number and contents of exosomes induced by resveratrol were determined by nanoparticle tracking analysis and high-throughput sequencing in Huh7 cells, respectively. Expression of Rab27a was assessed by Western blotting and immunofluorescence. Cell proliferation, migration and epithelial-mesenchymal transition were examined with the stimuli of resveratrol and exosomes, the activity of autophagy and wnt/β-catenin signaling induced by resveratrol-induced exosomes and knockdown of lncRNA SNHG29 were monitored by Western blotting and immunofluorescence.

Results:It was found that resveratrol might inhibit the exosome secretion by down-regulating the expression of Rab27a, thereby suppressing the proliferation, migration and epithelial-mesenchymal transition of Huh7 cells. Moreover, resveratrol-induced exosomes could also inhibit the malignant phenotype of Huh7 cells via inhibiting the nuclear translocation of β-catenin and the activation of autophagy, which lncRNA SNHG29 might mediate.

Conclusion:Resveratrol inhibits hepatocellular carcinoma progression by regulating exosome secretion and contents.

Об авторах

Kun Tong

Department of Laboratory Medicine, Taihe Hospital, Hubei University of Medicine

Email: info@benthamscience.net

Pingfeng Wang

Department of Laboratory Medicine, Taihe Hospital, Hubei University of Medicine

Email: info@benthamscience.net

Ying Li

Department of Laboratory Medicine, Taihe Hospital, Hubei University of Medicine

Email: info@benthamscience.net

Yaoyao Tong

Institute of Biomedical Research, Hubei Clinical Research Center for Precise Diagnosis and Treatment of HCC, Hubei University of Medicine

Email: info@benthamscience.net

Xuejie li

Department of Laboratory Medicine, Taihe Hospital, Hubei University of Medicine

Email: info@benthamscience.net

Shirong Yan

Department of Laboratory Medicine, Taihe Hospital, Hubei University of Medicine

Автор, ответственный за переписку.
Email: info@benthamscience.net

Pei Hu

Department of Laboratory Medicine, Taihe Hospital, Hubei University of Medicine

Автор, ответственный за переписку.
Email: info@benthamscience.net

Список литературы

  1. El-Serag, H.B. Hepatocellular carcinoma. N. Engl. J. Med., 2011, 365(12), 1118-1127. doi: 10.1056/NEJMra1001683 PMID: 21992124
  2. Tarantino, G.; Balsano, C.; Santini, S.J.; Brienza, G.; Clemente, I.; Cosimini, B.; Sinatti, G. It is high time physicians thought of natural products for alleviating NAFLD. Is there sufficient evidence to use them? Int. J. Mol. Sci., 2021, 22(24), 13424. doi: 10.3390/ijms222413424 PMID: 34948230
  3. Amiri, A.; Mahjoubin-Tehran, M.; Asemi, Z.; Shafiee, A.; Hajighadimi, S.; Moradizarmehri, S.; Mirzaei, H.R.; Mirzaei, H. Role of resveratrol in modulating micrornas in human diseases: From cancer to inflammatory disorder. Curr. Med. Chem., 2021, 28(2), 360-376. doi: 10.2174/1875533XMTAyiOTQi2 PMID: 31830882
  4. Almatroodi, S.A.; A Alsahli, M.; S M Aljohani, A.; Alhumaydhi, F.A.; Babiker, A.Y.; Khan, A.A.; Rahmani, A.H. Potential therapeutic targets of resveratrol, a plant polyphenol, and its role in the therapy of various types of cancer. Molecules, 2022, 27(9), 2665. doi: 10.3390/molecules27092665 PMID: 35566016
  5. Yang, R.; Dong, H.; Jia, S.; Yang, Z Resveratrol as a modulatory of apoptosis and autophagy in cancer therapy. Clin Transl Oncol, 2022, 24(7), 1219-1230.
  6. Zhang, L.; Yu, D. Exosomes in cancer development, metastasis, and immunity. Biochim. Biophys. Acta Rev. Cancer, 2019, 1871(2), 455-468. doi: 10.1016/j.bbcan.2019.04.004 PMID: 31047959
  7. Ostrowski, M.; Carmo, N.B.; Krumeich, S.; Fanget, I.; Raposo, G.; Savina, A.; Moita, C.F.; Schauer, K.; Hume, A.N.; Freitas, R.P. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol, 2010, 12(1), 19-30. doi: 10.1038/ncb2000
  8. Zhou, W.; Zheng, X.; Cheng, C.; Guo, G.; Zhong, Y.; Liu, W.; Liu, K.; Chen, Y.; Liu, S.; Liu, S. Rab27a deletion impairs the therapeutic potential of endothelial progenitor cells for myocardial infarction. Mol. Cell. Biochem., 2021, 476(2), 797-807. doi: 10.1007/s11010-020-03945-x PMID: 33095380
  9. Guo, K.; Feng, Y.; Zheng, X.; Sun, L.; Wasan, H.S.; Ruan, S.; Shen, M. Resveratrol and its analogs: Potent agents to reverse epithelial-to-mesenchymal transition in tumors. Front. Oncol., 2021, 11, 644134. doi: 10.3389/fonc.2021.644134 PMID: 33937049
  10. Pegtel, D.M.; Gould, S.J. Exosomes. Annu. Rev. Biochem., 2019, 88(1), 487-514. doi: 10.1146/annurev-biochem-013118-111902 PMID: 31220978
  11. Song, L.; Tang, S.; Han, X.; Jiang, Z.; Dong, L.; Liu, C.; Liang, X.; Dong, J.; Qiu, C.; Wang, Y.; Du, Y. KIBRA controls exosome secretion via inhibiting the proteasomal degradation of Rab27a. Nat. Commun., 2019, 10(1), 1639. doi: 10.1038/s41467-019-09720-x PMID: 30967557
  12. Guo, D.; Lui, G.Y.L.; Lai, S.L.; Wilmott, J.S.; Tikoo, S.; Jackett, L.A.; Quek, C.; Brown, D.L.; Sharp, D.M.; Kwan, R.Y.Q.; Chacon, D.; Wong, J.H.; Beck, D.; Geldermalsen, M.; Holst, J.; Thompson, J.F.; Mann, G.J.; Scolyer, R.A.; Stow, J.L.; Weninger, W.; Haass, N.K.; Beaumont, K.A. RAB27A promotes melanoma cell invasion and metastasis via regulation of pro-invasive exosomes. Int. J. Cancer, 2019, 144(12), 3070-3085. doi: 10.1002/ijc.32064 PMID: 30556600
  13. Li, X.; Li, C.; Zhang, L.; Wu, M.; Cao, K.; Jiang, F.; Chen, D.; Li, N.; Li, W. The significance of exosomes in the development and treatment of hepatocellular carcinoma. Mol. Cancer, 2020, 19(1), 1. doi: 10.1186/s12943-019-1085-0 PMID: 31901224
  14. Xie, Q.H.; Zheng, J.Q.; Ding, J.Y.; Wu, Y.F.; Liu, L.; Yu, Z.L.; Chen, G. Exosome-mediated immunosuppression in tumor microenvironments. Cells, 2022, 11(12), 1946. doi: 10.3390/cells11121946 PMID: 35741075
  15. Yang, K.; Zhou, Q.; Qiao, B.; Shao, B.; Hu, S.; Wang, G.; Yuan, W.; Sun, Z. Exosome-derived noncoding RNAs: Function, mechanism, and application in tumor angiogenesis. Mol. Ther. Nucleic Acids, 2022, 27, 983-997. doi: 10.1016/j.omtn.2022.01.009 PMID: 35317280
  16. Ge, Y.; Mu, W.; Ba, Q.; Li, J.; Jiang, Y.; Xia, Q.; Wang, H. Hepatocellular carcinoma-derived exosomes in organotropic metastasis, recurrence and early diagnosis application. Cancer Lett., 2020, 477, 41-48. doi: 10.1016/j.canlet.2020.02.003 PMID: 32112905
  17. Meng, W.; Hao, Y.; He, C.; Li, L.; Zhu, G. Exosome-orchestrated hypoxic tumor microenvironment. Mol. Cancer, 2019, 18(1), 57. doi: 10.1186/s12943-019-0982-6 PMID: 30925935
  18. Richards, K.E.; Zeleniak, A.E.; Fishel, M.L.; Wu, J.; Littlepage, L.E.; Hill, R. Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells. Oncogene, 2017, 36(13), 1770-1778. doi: 10.1038/onc.2016.353 PMID: 27669441
  19. Matsumoto, A.; Takahashi, Y.; Nishikawa, M.; Sano, K.; Morishita, M.; Charoenviriyakul, C.; Saji, H.; Takakura, Y. Accelerated growth of B16 BL 6 tumor in mice through efficient uptake of their own exosomes by B16 BL 6 cells. Cancer Sci., 2017, 108(9), 1803-1810. doi: 10.1111/cas.13310 PMID: 28667694
  20. Xue, M.; Chen, W.; Xiang, A.; Wang, R.; Chen, H.; Pan, J.; Pang, H.; An, H.; Wang, X.; Hou, H.; Li, X. Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1. Mol. Cancer, 2017, 16(1), 143. doi: 10.1186/s12943-017-0714-8 PMID: 28841829
  21. Chen, R.; Xu, X.; Tao, Y.; Qian, Z.; Yu, Y. Exosomes in hepatocellular carcinoma: A new horizon. Cell Commun. Signal., 2019, 17(1), 1. doi: 10.1186/s12964-018-0315-1 PMID: 30616541
  22. Yang, L.; Peng, X.; Li, Y.; Zhang, X.; Ma, Y.; Wu, C.; Fan, Q.; Wei, S.; Li, H.; Liu, J. Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma. Mol. Cancer, 2019, 18(1), 78. doi: 10.1186/s12943-019-0990-6 PMID: 30943982
  23. Chen, L.; Guo, P.; He, Y.; Chen, Z.; Chen, L.; Luo, Y.; Qi, L.; Liu, Y.; Wu, Q.; Cui, Y.; Fang, F.; Zhang, X.; Song, T.; Guo, H. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway. Cell Death Dis., 2018, 9(5), 513. doi: 10.1038/s41419-018-0534-9 PMID: 29725020
  24. Yazdani, H.; Huang, H.; Tsung, A. Autophagy: Dual response in the development of hepatocellular carcinoma. Cells, 2019, 8(2), 91. doi: 10.3390/cells8020091 PMID: 30695997
  25. Ma, W.; Zhou, Y.; Liu, M.; Qin, Q.; Cui, Y. Long non-coding RNA LINC00470 in serum derived exosome: A critical regulator for proliferation and autophagy in glioma cells. Cancer Cell Int., 2021, 21(1), 149. doi: 10.1186/s12935-021-01825-y PMID: 33663509
  26. Yao, W.; Guo, P.; Mu, Q.; Wang, Y. Exosome-derived circ-PVT1 contributes to cisplatin resistance by regulating autophagy, invasion, and apoptosis via miR-30a-5p/YAP1 axis in gastric cancer cells. Cancer Biother. Radiopharm., 2021, 36(4), 347-359. doi: 10.1089/cbr.2020.3578 PMID: 32799541

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© Bentham Science Publishers, 2024